1 |
许 静,陈 炜,张 鸿,等. 医院获得性肺炎的治疗及预防进展[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 123-126.
|
2 |
石 磊,韩晓华,黄 敏. 507例医院获得性肺炎患者克雷伯菌血流感染病原菌的耐药性分析及其对预后相关因素的影响[J]. 抗感染药学,2018, 15(9): 1557-1559.
|
3 |
许孙红,任 佳,翟耀勇. 革兰阴性菌感染医院获得性肺炎患者临床特征与耐药性分析[J]. 中华医院感染学杂志,2020, 30(11): 1683-1688.
|
4 |
孙 康,李王平,潘 蕾,等. 医院获得性铜绿假单胞菌肺炎危险因素分析[J]. 中华肺部疾病杂志,2022, 15(2): 166-170.
|
5 |
中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志,2018, 41(4): 255-280.
|
6 |
中华人民共和国卫生部.医院感染诊断标准(试行)[J]. 中华医学杂志,2001, 81(5): 314-320.
|
7 |
蒋昭清,陈 勍,干铁儿,等. 医院获得性肺炎克雷伯菌血流感染病原菌耐药性及预后影响因素分析[J]. 中华医院感染学杂志,2018, 28(8): 1135-1138.
|
8 |
付亚文,杜玉珍,高 锋. CLSI临床实验室自动化标准概述[J]. 检验医学,2018, 35(4): 370-373.
|
9 |
吴茱萸,唐思源,李耀军,等. 老年医院获得性肺炎病原菌感染特点及耐药性分析[J]. 中华医院感染学杂志,2017, 27(7): 1524-1527.
|
10 |
王 敏,马爱矿,王晓蓉. 老年社区获得性肺炎人群临床特点、危险因素以及病原菌的耐药性分析[J]. 中国卫生检验杂志,2017, 27(24): 3639-3641.
|
11 |
沈翠芬,张晓祥,辛少军. 院内获得性肺炎老年患者病原菌测定、耐药性以及危险因素分析[J]. 中国卫生检验杂志,2017, 27(17): 2572-2574.
|
12 |
Zhu XY, Wang HB, Zhu YH, et al. Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae[J]. Chin Med J (Engl), 2021, 134(14): 1735-1737.
|
13 |
Ensinck G, Lazarte G, Ernst A, et al. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia in a children′s hospital. Our ten-year experience[J]. Arch Argent Pediatr, 2021, 119(1): 11-17.
|
14 |
王吉燕,翟景梅,王丽霞. 2012-2017年某三级医院318例社区获得性肺炎及耐药性分析[J]. 哈尔滨医药,2020, 40(3): 211-212.
|
15 |
Balkan II, Alkan M, Aygun G, et al. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(10): 2161-2170.
|
16 |
Greninger AL, Naccache SN. Metagenomics to Assist in the Diagnosis of Bloodstream Infection[J]. J Appl Lab Med, 2019, 3(4): 643-653.
|
17 |
谭善娟,毕俏杰,李 玲,等. 成人社区及医院获得性肺炎病原菌及耐药性差异[J]. 中国感染控制杂志,2020, 19(9): 835-842.
|
18 |
Teng F, Liu X, Guo SB, et al. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients[J]. J Infect Chemother, 2019, 25(2): 129-136.
|
19 |
王带媚,赵二义,钟敬波,等. 神经内科重症监护病房医院获得性肺炎多重耐药菌感染的病原学分布及耐药性分析[J]. 中南药学,2018, 16(12): 1785-1788.
|
20 |
Kern WV, Rieg S. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens[J]. Clin Microbiol Infect,2020, 26(2): 151-157.
|
21 |
杜力巍,杨卫东,朱 珊,等. 医院获得性肺炎患者的病原菌分布及耐药率分析[J]. 中华医院感染学杂志,2017, 27(13): 2976-2979.
|
22 |
Elseady N, Khamis N, AbdelGhani S, et al. Antibiotic sensitivity/resistance pattern of hospital acquired blood stream infection in children cancer patients: A retrospective study[J]. Int J Clin Pract, 2021, 75(10): 617-619.
|
23 |
Soedarsono S, Widyaningsih PD, Mertaniasih NM. The risk factors of multidrug-resistant organisms in hospitalized patients with community-acquired pneumonia in Dr. Soetomo Hospital surabaya, indonesia[J]. Acta Med Indones, 2021, 53(2): 169-176.
|
24 |
白雪冬,毕丽岩. 医院获得性肺炎的危险因素和病原菌分布及耐药性分析[J]. 中国呼吸与危重监护杂志,2017, 16(1): 23-28.
|
25 |
Eshwara VK, Mukhopadhyay C, Rello J. Community-acquired bacterial pneumonia in adults: An update[J]. Indian J Med Res, 2020, 151(4): 287-302.
|
26 |
Klos M, Pomorska-Wesolowska M, Romaniszyn D, et al. Antimicrobial resistance in enterobacterales bacilli isolated from bloodstream infection in surgical patients of polish hospitals[J]. Int J Microbiol, 2021, 18(23): 148-152.
|
27 |
Solmaz I, Kalin BS. Assessment of antibiotic resistance of infectious agents in patients with pneumonia in tertiary critical care unit and effect on clinical outcomes [J]. Int J Clin Pract, 2021, 75(4): 872-875.
|
28 |
Modi AR, Kovacs CS. Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention[J]. Cleve Clin J Med, 2020, 87(10): 633-639.
|
29 |
Warren C, Medei MK, Wood B, et al. A Nurse-Driven Oral Care Protocol to Reduce Hospital-Acquired Pneumonia[J]. Am J Nurs, 2019, 119(2): 44-51.
|
30 |
Zaragoza R, Vidal-Cortés P, Aguilar G, et al. Update of the treatment of nosocomial pneumonia in the ICU[J]. Crit Care, 2020, 24(1): 383.
|